Brazil — Bharat WorldMeds

Brazil is India's #3 pharmaceutical export destination, receiving $663M in pharmaceutical products. Exports have grown 2.9× over the past decade — a trade relationship that has deepened significantly.

Dual-source profile. Both series show finished pharmaceutical products aligned to calendar year (Jan–Dec). Comex Stat records what Brazil imports from India. DGCIS records what India exports to Brazil. Category and product detail from DGCIS.

$663M

Scale

India supplies $663M in pharmaceutical products to Brazil each year — a substantial supply line of affordable medicine.

64%

Medicine

Primarily medicines (64%), supplemented by medicine ingredients and vaccines.

2.9×

Trajectory

Brazil's imports of Indian pharmaceutical products have grown 2.9× over the past decade — from $230M in 2014 to $663M in 2025.

Context

A top-three pharmaceutical export destination for India.

✦

Impact

Indian pharmaceutical companies have both exported to and invested directly in Brazil — building trade and operational presence.

$862M

Ranking Basis

India's official export data (DGCIS, FY 2025–26) records $862M in pharmaceutical products to Brazil — the figure behind the #3 ranking.

Additional pharmaceutical categories from DGCIS — APIs, surgical, herbal, and more

Medicines $553M (64.2%) Medicine Ingredients $233M (27.1%) Vaccines $44.4M (5.1%) Surgical & Hospital Supplies $26.8M (3.1%) Traditional & Herbal $4.3M (0.5%)

Active Pharmaceutical Ingredients DGCIS India-side

India also supplied $226M in active pharmaceutical ingredients and bulk drugs to Brazil in 2025 (India-reported, DGCIS).

Total RBI-approved ODI commitments by Indian pharmaceutical companies into Brazil: $66.2M across 43 filings (2011-2022).